These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 149578

  • 1. Vein surgery during defibrinogenation.
    Browse NL, Clemenson G.
    Br J Surg; 1978 Jul; 65(7):452-5. PubMed ID: 149578
    [Abstract] [Full Text] [Related]

  • 2. Experience of extensive vascular surgery on defibrase-defibrinogenated patients.
    Olsson P, Blombäck M, Egberg N, Ekeström S.
    Thromb Res; 1976 Sep; 9(3):277-87. PubMed ID: 982350
    [No Abstract] [Full Text] [Related]

  • 3. Reduction of thrombogenicity in small-diameter vascular prostheses seeded with autologous endothelial cells.
    Köveker GB, Petzke KH, Borg M, Nebendahl K.
    Thorac Cardiovasc Surg; 1986 Feb; 34(1):49-51. PubMed ID: 2421448
    [Abstract] [Full Text] [Related]

  • 4. [Studies on blood coagulation systems during defibrinogenation therapy with batroxobin (Bothrops atrox venom) (author's transl)].
    Ishimaru S, Konishi M, Furukawa K, Takahashi M, Fujimaki M.
    Rinsho Ketsueki; 1979 May; 20(5):500-9. PubMed ID: 465131
    [No Abstract] [Full Text] [Related]

  • 5. Hemodilution combined with defibrinogenation.
    Böhme H, Everts B.
    Bibl Haematol; 1981 May; (47):165-72. PubMed ID: 7039611
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E.
    Int Angiol; 1985 May; 4(3):373-7. PubMed ID: 3913715
    [Abstract] [Full Text] [Related]

  • 7. Proceedings: Anticoagulation during six hours of extracorporeal perfusion. Comparison between heparinization and defibrinogenation.
    Berglin E, Hansson HA, Teger-Nilsson AC, Williams-Olsson G.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):578. PubMed ID: 1198477
    [No Abstract] [Full Text] [Related]

  • 8. [Role of natural killer cells in the antimetastatic effect of defibrinogenation with batroxobin].
    Shibuya M, Kawachi S, Aoyama A, Murata A, Baba M, Hirata K, Ohtsuka M, Matsusaka M, Yano T, Niitani H.
    Gan To Kagaku Ryoho; 1987 Jul 15; 14(7):2286-92. PubMed ID: 3300562
    [Abstract] [Full Text] [Related]

  • 9. [Surgical arteriovenous fistula as a preventive method against thrombosis of vascular prosthetic grafts. (Experimental research)].
    Nasta AG, Sorice G, Anfossi A, Bernardini R.
    Chir Patol Sper; 1971 Apr 15; 19(2):61-76. PubMed ID: 4265011
    [No Abstract] [Full Text] [Related]

  • 10. Effect of defibrination with batroxobin on growth and metastasis of JW sarcoma in mice.
    Chmielewska J, Poggi A, Janik P, Latallo ZS, Donati MB.
    Eur J Cancer (1965); 1980 Jul 15; 16(7):919-23. PubMed ID: 7000518
    [No Abstract] [Full Text] [Related]

  • 11. Defibrinogenation treatment in patients suffering from severe intermittent claudication - a controlled study.
    Martin M, Hirdes E, Auel H.
    Thromb Res; 1976 Jul 15; 9(1):47-57. PubMed ID: 785691
    [No Abstract] [Full Text] [Related]

  • 12. Prosthetic arteriovenous fistula for vascular access in hemodialysis.
    Levowitz BS, Flores L, Dunn I, Frumkin E.
    Am J Surg; 1976 Sep 15; 132(3):368-72. PubMed ID: 134645
    [Abstract] [Full Text] [Related]

  • 13. Improvement in experimental vascular graft patency by controlled defibrinogenation.
    Postlethwaite JC, Goyle KB, Dormandy JA, Hynd JW.
    Br J Surg; 1977 Jan 15; 64(1):28-30. PubMed ID: 137762
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E.
    MMW Munch Med Wochenschr; 1983 Sep 16; 125(37):796-8. PubMed ID: 6415441
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of acute experimental arterial thrombosis by defibrination.
    Haimov M, Danese C.
    Vasc Surg; 1973 Sep 16; 7(4):206-12. PubMed ID: 4762281
    [No Abstract] [Full Text] [Related]

  • 16. Haemostatic clot formation at anastomosis of synthetic venous graft in defibrinogenated dogs: a scanning electron microscopic study.
    Ishimaru S, Berglin E, Hansson HA, Teger-Nilsson AC, William-Olsson G.
    Thromb Haemost; 1981 Jun 30; 45(3):276-81. PubMed ID: 7025342
    [Abstract] [Full Text] [Related]

  • 17. Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
    Nishimura H, Takahashi K, Sakurai K, Fujinuma K, Imamura Y, Ooba M, Inada Y.
    Life Sci; 1983 Oct 10; 33(15):1467-73. PubMed ID: 6353117
    [Abstract] [Full Text] [Related]

  • 18. Newer tissue and synthetic grafts in canine femoral veins.
    Hiratzka LF, Doty DB, Wright CB.
    J Surg Res; 1981 Oct 10; 31(4):324-31. PubMed ID: 6457221
    [No Abstract] [Full Text] [Related]

  • 19. The influence of automatic vascular suturing and arterio-venous shunting on the patency of small dacron grafts in dogs.
    Van Osselaer G, Ponette E, De Geest H, Stalpaert G.
    J Cardiovasc Surg (Torino); 1968 Oct 10; 9(2):170-7. PubMed ID: 4873319
    [No Abstract] [Full Text] [Related]

  • 20. Iliac vein obstruction associated with acute iliofemoral venous thrombosis. Results of early reconstruction using polytetrafluoroethylene grafts.
    Plate G, Einarsson E, Eklöf B, Jensen R, Ohlin P.
    Acta Chir Scand; 1985 Oct 10; 151(7):607-11. PubMed ID: 4090887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.